Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
Floegel A, Stefan N, Yu Z, Mühlenbruch K, Drogan D, Joost HG, Fritsche A, Häring HU, Hrabě de Angelis M, Peters A, Roden M, Prehn C, Wang-Sattler R, Illig T, Schulze MB, Adamski J, Boeing H, Pischon T. Floegel A, et al. Among authors: hrabe de angelis m. Diabetes. 2013 Feb;62(2):639-48. doi: 10.2337/db12-0495. Epub 2012 Oct 4. Diabetes. 2013. PMID: 23043162 Free PMC article.
Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver.
Lehmann R, Franken H, Dammeier S, Rosenbaum L, Kantartzis K, Peter A, Zell A, Adam P, Li J, Xu G, Königsrainer A, Machann J, Schick F, Hrabé de Angelis M, Schwab M, Staiger H, Schleicher E, Gastaldelli A, Fritsche A, Häring HU, Stefan N. Lehmann R, et al. Among authors: hrabe de angelis m. Diabetes Care. 2013 Aug;36(8):2331-8. doi: 10.2337/dc12-1760. Epub 2013 Mar 20. Diabetes Care. 2013. PMID: 23514731 Free PMC article.
Type 2 diabetes alters metabolic and transcriptional signatures of glucose and amino acid metabolism during exercise and recovery.
Hansen JS, Zhao X, Irmler M, Liu X, Hoene M, Scheler M, Li Y, Beckers J, Hrabĕ de Angelis M, Häring HU, Pedersen BK, Lehmann R, Xu G, Plomgaard P, Weigert C. Hansen JS, et al. Among authors: hrabe de angelis m. Diabetologia. 2015 Aug;58(8):1845-54. doi: 10.1007/s00125-015-3584-x. Epub 2015 Jun 12. Diabetologia. 2015. PMID: 26067360
Bezafibrate Improves Insulin Sensitivity and Metabolic Flexibility in STZ-Induced Diabetic Mice.
Franko A, Huypens P, Neschen S, Irmler M, Rozman J, Rathkolb B, Neff F, Prehn C, Dubois G, Baumann M, Massinger R, Gradinger D, Przemeck GK, Repp B, Aichler M, Feuchtinger A, Schommers P, Stöhr O, Sanchez-Lasheras C, Adamski J, Peter A, Prokisch H, Beckers J, Walch AK, Fuchs H, Wolf E, Schubert M, Wiesner RJ, Hrabě de Angelis M. Franko A, et al. Among authors: hrabe de angelis m. Diabetes. 2016 Sep;65(9):2540-52. doi: 10.2337/db15-1670. Epub 2016 Jun 9. Diabetes. 2016. PMID: 27284107
TGF-β Contributes to Impaired Exercise Response by Suppression of Mitochondrial Key Regulators in Skeletal Muscle.
Böhm A, Hoffmann C, Irmler M, Schneeweiss P, Schnauder G, Sailer C, Schmid V, Hudemann J, Machann J, Schick F, Beckers J, Hrabě de Angelis M, Staiger H, Fritsche A, Stefan N, Nieß AM, Häring HU, Weigert C. Böhm A, et al. Among authors: hrabe de angelis m. Diabetes. 2016 Oct;65(10):2849-61. doi: 10.2337/db15-1723. Epub 2016 Jun 29. Diabetes. 2016. PMID: 27358493 Clinical Trial.
Impact of fibroblast growth factor 21 on the secretome of human perivascular preadipocytes and adipocytes: a targeted proteomics approach.
Berti L, Hartwig S, Irmler M, Rädle B, Siegel-Axel D, Beckers J, Lehr S, Al-Hasani H, Häring HU, Hrabě de Angelis M, Staiger H. Berti L, et al. Among authors: hrabe de angelis m. Arch Physiol Biochem. 2016 Dec;122(5):281-288. doi: 10.1080/13813455.2016.1212898. Epub 2016 Aug 5. Arch Physiol Biochem. 2016. PMID: 27494767
Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
Franko A, Neschen S, Rozman J, Rathkolb B, Aichler M, Feuchtinger A, Brachthäuser L, Neff F, Kovarova M, Wolf E, Fuchs H, Häring HU, Peter A, Hrabě de Angelis M. Franko A, et al. Among authors: hrabe de angelis m. Mol Metab. 2017 Jan 6;6(3):256-266. doi: 10.1016/j.molmet.2016.12.007. eCollection 2017 Mar. Mol Metab. 2017. PMID: 28271032 Free PMC article.
Fibroblast Growth Factor 21-Metabolic Role in Mice and Men.
Staiger H, Keuper M, Berti L, Hrabe de Angelis M, Häring HU. Staiger H, et al. Among authors: hrabe de angelis m. Endocr Rev. 2017 Oct 1;38(5):468-488. doi: 10.1210/er.2017-00016. Endocr Rev. 2017. PMID: 28938407 Review.
Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.
Sabrautzki S, Kaiser G, Przemeck GKH, Gerst F, Lorza-Gil E, Panse M, Sartorius T, Hoene M, Marschall S, Häring HU, Hrabě de Angelis M, Ullrich S. Sabrautzki S, et al. Among authors: hrabe de angelis m. Mol Metab. 2017 Oct;6(10):1304-1312. doi: 10.1016/j.molmet.2017.07.007. Epub 2017 Jul 18. Mol Metab. 2017. PMID: 29031729 Free PMC article.
370 results